In this work, we investigated the potential antitumor effects of AdRGD-PG-IFNβ and AdRGD-PG-p14ARF in a model of in situ gene therapy using the human melanoma cell line SK-MEL-147 engrafted in Nod-Scid mice. This evidence concerns the gene IFNB1 and melanoma.